Company Overview: DERM

Upcoming Projects (DERM)

Don’t see a project related to the company you care about? Create your own!

Executed Projects (DERM)

Don’t see a project related to the company you care about? Create your own!

Upcoming & Overdue Catalysts (DERM)

Don’t see a catalyst related to the company you care about? Create your own!

Occurred Catalysts (DERM)

AnaptysBio's (ANAB) Etokimab ATLAS Phase 2b Clinical Trial in Moderate-to-Severe Atopic Dermatitis Data Released
Tickers: ANAB, DERM
Occurred on: Nov 08, 2019
Data Released From Dermira's (DERM) Phase 2b Study of Lebrikizumab in Patients With Atopic Dermatitis at Fall Clinical Dermatology Conference
Ticker: DERM
Occurred on: Oct 17, 2019
Olumacostat glasaretil CLAREOS-1 Phase 3 clinical trial topline results in patients with acne vulgaris expected in the first half of 2018 -Did Not Meet Co-Primary Endpoints, Discontinued
Ticker: DERM
Occurred on: Mar 05, 2018
Dermira (DERM) Initiates Phase 2b Dose-Ranging Study Evaluating Lebrikizumab in Patients with Moderate-to-Severe Atopic Dermatitis
Ticker: DERM
Occurred on: Jan 31, 2018
NDA Fililng for DRM04 in treating Primary axiliary hyperhidrosis expected in 2H 2017
Ticker: DERM
Occurred on: Nov 06, 2017
Submission of marketing applications by UCB for CIMZIA for the treatment of moderate-to-severe chronic plaque psoriasis expected in the third quarter of 2017
Tickers: DERM, UCBB.F
Occurred on: Jul 25, 2017
Olumacostat Glasaretil Phase 2b Dose-Ranging Study in Acne Vulgaris Data Presented at American Academy of Dermatology 2017 Annual Meeting
Ticker: DERM
Occurred on: Mar 03, 2017
Glycopyrronium Tosylate Phase 3 Data in Primary Axillary Hyperhidrosis Presented at American Academy of Dermatology 2017 Annual Meeting
Ticker: DERM
Occurred on: Mar 03, 2017
New CIMZIA (certolizumab pegol) data in moderate-to-severe plaque psoriasis and psoriatic arthritis presented at American Academy of Dermatology 2017 Annual Meeting
Tickers: DERM, UNC.F
Occurred on: Mar 02, 2017
Phase 3 data of Cimzia (certolizumab pegol) for Moderate-to-severe plaque psoriasis due by end of 1Q 2017
Ticker: DERM
Occurred on: Jan 19, 2017
Dermira (DERM) Expects Initiation of Phase 3 Trial in H1 2017 Evaluating DRM01 for Acne Vulgaris
Ticker: DERM
Occurred on: Jan 03, 2017
Dermira Completes Patient Enrollment for DRM04 Phase 3 Pivotal Trials in Primary Axillary Hyperhidrosis; Topline Results for Phase 3 ATMOS-1 and ATMOS-2 Clinical Trials Expected in 2Q 2016
Ticker: DERM
Occurred on: Jun 01, 2016

Strategic Initiatives (DERM)

Lilly (LLY) Completes Acquisition of Dermira (DERM)
Tickers: LLY, DERM
Announcement Date: Feb 20, 2020

DERM Overview